PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network (NCCN) will convene policymakers, researchers, patient advocates, and industry leaders on June 25 to examine how cancer innovation is funded and sustained, as advances in oncology accelerate amid growing debate over healthcare costs, research investment, and patient access to new treatments.
The virtual NCCN Policy Summit Webinar, titled Innovations in Cancer Care Through the Ages, will explore how breakthroughs in cancer therapies and treatment approaches have transformed patient care while assessing the financial and policy frameworks that support continued research and development.
The discussion comes as the oncology sector experiences rapid advances in areas such as immunotherapy, targeted therapies, precision medicine, and early detection technologies, developments that have improved outcomes for many patients but also increased attention on the costs and sustainability of innovation.
According to NCCN, the summit will examine how collaborative research environments contributed to past advances in cancer care, identify emerging opportunities for future innovation, and evaluate challenges facing the current clinical research ecosystem.
The event will feature congressional remarks from Diana DeGette, who has long been involved in healthcare and biomedical research policy discussions.
The keynote address will be delivered by Christopher Lieu, co-director of gastrointestinal medical oncology at the University of Colorado Cancer Center and vice chair of the NCCN Board of Directors.
A patient perspective will be provided by Robert Dilley, a clinical fellow at Dana-Farber Cancer Institute.
Additional speakers include James H. Doroshow, director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute; Randy Burkholder, vice president of policy and research at the Pharmaceutical Research and Manufacturers of America; Cassadie Moravek, senior director of strategic collaborations and patient advocacy at the Pancreatic Cancer Action Network; and Katharine Rendle, director of the Penn Center for Cancer Care Innovation.
The summit is scheduled to run from 1 p.m. to 3:30 p.m. EDT on June 25 and is intended to bring together perspectives from patients, providers, payers, researchers, advocates, and policymakers on the future of cancer care innovation.
Additional information, the full agenda, and registration details are available at NCCN.org/summits.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.